A detailed history of Dafna Capital Management LLC transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 895,200 shares of RGLS stock, worth $1.33 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
895,200
Previous 1,070,548 16.38%
Holding current value
$1.33 Million
Previous $3.08 Million 48.04%
% of portfolio
0.41%
Previous 0.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.79 - $2.8 $313,872 - $490,974
-175,348 Reduced 16.38%
895,200 $1.6 Million
Q1 2024

May 15, 2024

SELL
$1.13 - $2.88 $45,766 - $116,642
-40,501 Reduced 3.65%
1,070,548 $3.08 Million
Q2 2023

Aug 14, 2023

BUY
$0.87 - $1.75 $483,279 - $972,114
555,494 Added 99.99%
1,111,049 $1.63 Million
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.4 $888,888 - $1.89 Million
555,555 New
555,555 $1.15 Million

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $21.8M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.